<DOC>
	<DOCNO>NCT00674453</DOCNO>
	<brief_summary>The objective study demonstrate effect lasofoxifene serum marker bone metabolism .</brief_summary>
	<brief_title>The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<criteria>Postmenopausal woman 50 year low bone mineral density . Women 50 year age , premenopausal , currently osteoporosis exclude .</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Osteoporosis</keyword>
	<keyword>lasofoxifene</keyword>
	<keyword>bone density</keyword>
	<keyword>bone marker</keyword>
</DOC>